Merck Prestige® WNV Equine Vaccine 10 mL/10 Dose

Merck Prestige® WNV Equine Vaccine 10 mL/10 Dose

INDICATIONS

This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against West Nile Virus. Duration of immunity has not been established.

• WNV is considered a core vaccination recommended by the AAEP vaccine guidelines and is indicated in the immunization program for all horses each year.
• Advanced filtration process through the Antigen Purification System (APS™)
• Exceptional safety profile with the exclusive Havlogen^® Adjuvant

Dose
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in foals and additional boosters will be required in most young animals. For more information on revaccination frequency, consult your veterinarian.